CHU de Clermont-Ferrand Awards €951M Medical Consumables Framework Agreements

Centre Hospitalier Universitaire de Clermont-Ferrand, a body governed by public law operating in health, has awarded framework agreements for the supply of medical devices segment 1 (PDM18 : AO2026 PHARMAUVERGNE FOURNITURES DISPOSITIFS MEDICAUX SEGMENT 1). The maximum value of the framework agreements in this notice is €951,014,187.82, covering medical consumables, with a maximum contract duration of 48 months. The contracts were awarded following an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Introduction

Centre Hospitalier Universitaire de Clermont-Ferrand, a body governed by public law operating in health, has conducted an open procedure launched by a group of purchasers under the conditions defined in the specification. The framework agreement will be executed by issuing purchase orders. Each lot will be awarded separately. The estimated value in the announcement corresponds to the annual value of the contract. The amounts in euros excluding VAT estimated in the document "Estimation montants lot et nomenclature pdm18" are annual.

The procurement is not financed with EU funds but is covered by the Government Procurement Agreement (GPA). The framework agreements are concluded without reopening of competition. The contract period runs initially from 01/03/2026 to 28/02/2027, or in case of later notification, from the date of notification, until 28/02/2027. The expected completion date is 28/02/2030. The framework agreement is tacitly renewed until its term. The number of renewal periods is 3, each of 12 months. The maximum contract duration, all periods combined, is 48 months. The price is the only award criterion (100%). 195 tenders were received. Numerous winners were appointed across nine lots. Subcontracting is not yet known. The contracts were concluded on 01/03/2026. The maximum value of the framework agreements in this notice is €951,014,187.82.

Why This Contract Matters

This contract ensures the supply of medical consumables for the Centre Hospitalier Universitaire de Clermont-Ferrand and the PHARMAUVERGNE group of purchasers, supporting hospital medical operations across multiple clinical specialities.

This contract matters because it:

• Supports Hospital Operations: Supplies medical consumables across urology, nephrology, urodynamic exploration, dressings, gynaecology, pulmonary, anaesthesia, cardiology, biopsy and drainage, and nervous system exploration
• Significant Value: €951,014,187.82 maximum framework value
• Medium-Term Commitment: Maximum 48 months (initial 12 months plus 3 renewal periods of 12 months)
• Comprehensive Scope: Medical consumables across nine lots
• Price-Based Evaluation: 100% price
• Competition: 195 tenders received electronically
• Subcontracting: Not yet known

Contract Timeline

• Contract concluded: 01/03/2026
• Initial period: 01/03/2026 – 28/02/2027
• Expected completion date: 28/02/2030
• Maximum duration: 48 months (all periods combined)
• Notice published: 06 October 2026 (OJ S 193/2026)
• Notice dispatch date: 05 October 2026

Contract Overview

Centre Hospitalier Universitaire de Clermont-Ferrand conducted an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Key features include:

• Nine lots: LOT-0001 to LOT-0009
• Maximum value: €951,014,187.82
• Duration: Maximum 48 months (initial 12 months plus 3 renewals of 12 months)
• Framework type: Framework agreement, without reopening of competition
• Evaluation: Price (100%)
• Winners: Numerous suppliers across nine lots
• Subcontracting: Not yet known
• No EU funding
• Covered by GPA: Yes
• Strategic procurement: Approach to reducing environmental impacts – Other

Key Contract Details

• Main classification: 33140000 Medical consumables
• Additional classification: 33140000 Medical consumables
• Place of performance: France
• Procedure identifier: 7f9f01e9-5a81-42c0-b81c-3a0d6deaf982
• Internal identifier: PDM18
• Type of procedure: Open
• Accelerated procedure: No
• Legal basis: Directive 2014/24/EU
• Review body: Tribunal administratif de Clermont-Ferrand

Lot Structure

Lot 1 – Consumable Medical Devices for Urology, Nephrology (Lots 1 to 91)

• Title: Lot 1 : DISPOSITIFS MEDICAUX CONSOMMABLES POUR UROLOGIE, NEPHROLOGIE Lots 1 à 91
• Internal identifier: 1
• Winner examples: AMBU SARL (€506,880.00), ASEPT INMED (€610,350.64), BOSTON SCIENTIFIC (€440,089.18), BBRAUN (€338,332.24), VYGON (€2,205,577.34)
• Tenders received: 195
• Contract concluded: 01/03/2026
• Duration: Initial 01/03/2026 – 28/02/2027; maximum 48 months

Lot 2 – Urodynamic Exploration Medical Devices (Lots 92 to 103)

• Title: Lot 2 : DISPOSITIFS MEDICAUX D'EXPLORATION URODYNAMIQUE Lots 92 à 103
• Internal identifier: 2
• Winners: CREO MEDICAL (€6,414.60), INT AIR MEDICAL (€378.40), SLG MEDICAL (€3,014,920.00)
• Tenders received: 195
• Contract concluded: 01/03/2026
• Duration: Initial 01/03/2026 – 28/02/2027; maximum 48 months

Lot 3 – Dressings, Compression and Wound Treatment Items (Lots 104 to 229)

• Title: Lot 3 : OBJETS DE PANSEMENTS, DE CONTENTION ET TRAITEMENT DES PLAIES Lots 104 à 229
• Internal identifier: 3
• Winner examples: ADA ALBINO DIAS DE ANDRADE (€17,263.00), BROTHIER / ALLOGA (€996,518.68), COLLIN MEDICAL (€2,120,258.00), LABORATOIRES PAUL HARTMANN (€38,880,893.93), MEDTRONIC FRANCE SAS (€22,995,026.00)
• Tenders received: 195
• Contract concluded: 01/03/2026
• Duration: Initial 01/03/2026 – 28/02/2027; maximum 48 months

Lot 4 – Consumable Medical Devices for Gynaecology (Lots 230 to 285)

• Title: Lot 4 : DISPOSITIFS MEDICAUX CONSOMMABLES POUR GYNECOLOGIE Lots 230 à 285
• Internal identifier: 4
• Winner examples: BOSTON SCIENTIFIC SA (€4,812,000.00), HELIOSCOPIE (€42,108,000.00), KEBOMED FRANCE (€11,578,721.00), LAMIDEY NOURY MEDICAL (€6,480,000.00)
• Tenders received: 195
• Contract concluded: 01/03/2026
• Duration: Initial 01/03/2026 – 28/02/2027; maximum 48 months

Lot 5 – Consumable Medical Devices for Pulmonary Approach (Lots 286 to 371)

• Title: Lot 5 : DISPOSITIFS MEDICAUX CONSOMMABLES POUR ABORD PULMONAIRE Lots 286 à 371
• Internal identifier: 5
• Winner examples: AMBU S.A.R.L (€480,592.40), INTERSURGICAL (€603,784.80), MEDTRONIC FRANCE SAS (€1,074,800.00)
• Tenders received: 195
• Contract concluded: 01/03/2026
• Duration: Initial 01/03/2026 – 28/02/2027; maximum 48 months

Lot 6 – Consumable Medical Devices for Anaesthesia and Intensive Care (Lots 372 to 426)

• Title: Lot 6 : DISPOSITIFS MEDICAUX CONSOMMABLES POUR ANESTHESIE REANIMATION Lots 372 à 426
• Internal identifier: 6
• Winner examples: B BRAUN MEDICAL SAS (€476,296.83), GETINGE FRANCE (€535,532.80), TELEFLEX MEDICAL SAS (€549,467.10)
• Tenders received: 195
• Contract concluded: 01/03/2026
• Duration: Initial 01/03/2026 – 28/02/2027; maximum 48 months

Lot 7 – Medical Devices for Cardiology (Lots 427 to 512)

• Title: Lot 7 : DISPOSITIFS MEDICAUX POUR CARDIOLOGIE Lots 427 à 512
• Internal identifier: 7
• Winner examples: ABBOTT MEDICAL France (€6,892,000.43), BIOTRONIK FRANCE (€9,355,110.61), BOSTON SCIENTIFIC SA (€12,245,583.81), EDWARDS LIFESCIENCES SAS (€9,234,960.00), MEDTRONIC FRANCE SAS (€30,006,463.18), MICROPORT (LIVANOVA) (€7,705,233.92)
• Tenders received: 195
• Contract concluded: 01/03/2026
• Duration: Initial 01/03/2026 – 28/02/2027; maximum 48 months

Lot 8 – Consumable Medical Devices for Biopsy and Drainage (Lots 513 to 566)

• Title: Lot 8 : DISPOSITIFS MEDICAUX CONSOMMABLES POUR BIOPSIE ET DRAINAGE Lots 513 à 566
• Internal identifier: 8
• Winner examples: ATOS MEDICAL (€345,800.00), DUOMED FRANCE (€483,356.80), COLOPLAST (€203,274.44)
• Tenders received: 195
• Contract concluded: 01/03/2026
• Duration: Initial 01/03/2026 – 28/02/2027; maximum 48 months

Lot 9 – Medical Devices for Nervous System Exploration (Lots 567 to 602)

• Title: Lot 9 : DISPOSITIFS MEDICAUX d'EXPLORATION DU SYSTÈME NERVEUX Lots 567 à 602
• Internal identifier: 9
• Winner examples: BALT EXTRUSION (€791,853.22), MICROVENTION® EUROPE (€2,305,467.23), PENUMBRA FRANCE SAS (€676,384.00), STRYKER FRANCE (€1,348,789.56)
• Tenders received: 195
• Contract concluded: 01/03/2026
• Duration: Initial 01/03/2026 – 28/02/2027; maximum 48 months

Lot Summary Table

Lot	Title	Value (€)	Winner examples	Tenders
1	Consumable Medical Devices for Urology, Nephrology (Lots 1 to 91)	506,880.00 / 610,350.64 / 440,089.18 / 338,332.24 / 2,205,577.34	AMBU SARL; ASEPT INMED; BOSTON SCIENTIFIC; BBRAUN; VYGON	195
2	Urodynamic Exploration Medical Devices (Lots 92 to 103)	6,414.60 / 378.40 / 3,014,920.00	CREO MEDICAL; INT AIR MEDICAL; SLG MEDICAL	195
3	Dressings, Compression and Wound Treatment Items (Lots 104 to 229)	17,263.00 / 996,518.68 / 2,120,258.00 / 38,880,893.93 / 22,995,026.00	ADA ALBINO DIAS DE ANDRADE; BROTHIER / ALLOGA; COLLIN MEDICAL; LABORATOIRES PAUL HARTMANN; MEDTRONIC FRANCE SAS	195
4	Consumable Medical Devices for Gynaecology (Lots 230 to 285)	4,812,000.00 / 42,108,000.00 / 11,578,721.00 / 6,480,000.00	BOSTON SCIENTIFIC SA; HELIOSCOPIE; KEBOMED FRANCE; LAMIDEY NOURY MEDICAL	195
5	Consumable Medical Devices for Pulmonary Approach (Lots 286 to 371)	480,592.40 / 603,784.80 / 1,074,800.00	AMBU S.A.R.L; INTERSURGICAL; MEDTRONIC FRANCE SAS	195
6	Consumable Medical Devices for Anaesthesia and Intensive Care (Lots 372 to 426)	476,296.83 / 535,532.80 / 549,467.10	B BRAUN MEDICAL SAS; GETINGE FRANCE; TELEFLEX MEDICAL SAS	195
7	Medical Devices for Cardiology (Lots 427 to 512)	6,892,000.43 / 9,355,110.61 / 12,245,583.81 / 9,234,960.00 / 30,006,463.18 / 7,705,233.92	ABBOTT MEDICAL France; BIOTRONIK FRANCE; BOSTON SCIENTIFIC SA; EDWARDS LIFESCIENCES SAS; MEDTRONIC FRANCE SAS; MICROPORT (LIVANOVA)	195
8	Consumable Medical Devices for Biopsy and Drainage (Lots 513 to 566)	345,800.00 / 483,356.80 / 203,274.44	ATOS MEDICAL; DUOMED FRANCE; COLOPLAST	195
9	Medical Devices for Nervous System Exploration (Lots 567 to 602)	791,853.22 / 2,305,467.23 / 676,384.00 / 1,348,789.56	BALT EXTRUSION; MICROVENTION® EUROPE; PENUMBRA FRANCE SAS; STRYKER FRANCE	195
Total		951,014,187.82

Scope of Supply

The contract covers the following supplies:

• Medical Consumables: Consumable medical devices across nine lots under CPV 33140000
• Urology and Nephrology: Consumable medical devices for urology and nephrology (Lots 1 to 91)
• Urodynamic Exploration: Medical devices for urodynamic exploration (Lots 92 to 103)
• Dressings and Wound Treatment: Dressings, compression and wound treatment items (Lots 104 to 229)
• Gynaecology: Consumable medical devices for gynaecology (Lots 230 to 285)
• Pulmonary Approach: Consumable medical devices for pulmonary approach (Lots 286 to 371)
• Anaesthesia and Intensive Care: Consumable medical devices for anaesthesia and intensive care (Lots 372 to 426)
• Cardiology: Medical devices for cardiology (Lots 427 to 512)
• Biopsy and Drainage: Consumable medical devices for biopsy and drainage (Lots 513 to 566)
• Nervous System Exploration: Medical devices for nervous system exploration (Lots 567 to 602)

Special Procurement Conditions

• Price Criterion: Price is the only award criterion (100%)
• Framework Agreement: Framework agreement, without reopening of competition
• Subcontracting: Not yet known
• Strategic Procurement: Approach to reducing environmental impacts – Other
• Variants: No variants are allowed; however, "options" are possible and are understood as range supplements to the basic offer
• Renewals: Maximum 3 renewal periods, each of 12 months; maximum contract duration 48 months

About the Contracting Authority

Centre Hospitalier Universitaire de Clermont-Ferrand is a body governed by public law operating in health in France.

• Legal type: Body governed by public law
• Activity: Health
• Registration number: 55889
• Location: Clermont-Ferrand, Puy-de-Dôme (FRK14), France
• Postcode: 63003
• Email: correspondre@aws-france.com
• Telephone: 0473750750
• Internet address: https://www.chu-clermontferrand.fr/
• Buyer profile: https://www.agysoft.marches-publics.info/

About the Winning Supplier

Numerous suppliers were awarded contracts across the nine lots, including (examples):

• AMBU SARL – Large enterprise, based in Bordeaux, France (LOT-0001, LOT-0005)
• ASEPT INMED SA – Large enterprise, based in Quint-Fonsegrives, France (LOT-0001, LOT-0005, LOT-0006, LOT-0008)
• BOSTON SCIENTIFIC SA – Large enterprise, based in Montigny-Le-Bretonneux, France (LOT-0001, LOT-0004, LOT-0007)
• MEDTRONIC FRANCE SAS – Large enterprise, based in Paris, France (LOT-0003, LOT-0005, LOT-0006, LOT-0007, LOT-0009)
• LABORATOIRES PAUL HARTMANN – Large enterprise, based in Chatenois, France (LOT-0003)
• VYGON – Large enterprise, based in Ecouen, France (LOT-0001, LOT-0005, LOT-0006, LOT-0008)
• TELEFLEX MEDICAL SAS – Large enterprise, based in Le Faget, France (LOT-0003, LOT-0005, LOT-0006, LOT-0007, LOT-0008)
• ABBOTT MEDICAL France – Large enterprise, based in Issy-Les-Moulineaux, France (LOT-0007)
• BIOTRONIK FRANCE – Large enterprise, based in Rungis, France (LOT-0007)
• EDWARDS LIFESCIENCES SAS – Large enterprise, based in Guyancourt, France (LOT-0007)
• MICROPORT (LIVANOVA) – Large enterprise, based in Clamart, France (LOT-0007)
• STRYKER FRANCE – Large enterprise, based in Pusignan, France (LOT-0009)
• MICROVENTION® EUROPE – Large enterprise, based in Saint-Germain-En-Laye, France (LOT-0009)
• BALT EXTRUSION – Large enterprise, based in Montmorency, France (LOT-0009)
• PENUMBRA FRANCE SAS – Large enterprise, based in Paris, France (LOT-0009)

Evaluation Criteria

The lots use the following evaluation criteria:

• Price (100%): Price is the only award criterion

Procurement Analysis

• Procedure: Open procedure under the standard regime, governed by EU Directive 2014/24/EU
• Competition: 195 tenders received electronically
• Subcontracting: Not yet known
• No EU funding: The procurement was not financed with EU funds
• Framework agreement: Framework agreement, without reopening of competition
• No dynamic purchasing system used
• Accelerated procedure: No
• Strategic procurement: Approach to reducing environmental impacts – Other
• Review body: Tribunal administratif de Clermont-Ferrand

Additional Procurement Facts

• The contract is covered by the WTO's Government Procurement Agreement (GPA)
• No EU funds were used for this procurement
• The maximum framework value is €951,014,187.82
• The procurement is divided into nine lots
• Price (100%) is the evaluation criterion
• 195 tenders were received electronically
• The winners are large enterprises
• Subcontracting is not yet known
• The maximum contract duration is 48 months (initial 12 months plus 3 renewals of 12 months)
• The expected completion date is 28/02/2030
• The contracts were concluded on 01/03/2026

Market & Industry Perspective

The French public sector medical consumables market features a mix of large and medium-sized enterprises. Medical consumables are essential for maintaining and developing hospital medical operations across multiple clinical specialities.

Key trends in this market include:

• Price-based evaluation: 100% price
• Large providers: Winners are large enterprises
• Comprehensive scope: Medical consumables across nine lots covering urology, nephrology, urodynamic exploration, dressings, gynaecology, pulmonary, anaesthesia, cardiology, biopsy and drainage, and nervous system exploration
• Medium-term projects: Maximum 48 months
• Specialised supplies: Consumable medical devices for multiple clinical specialities
• Subcontracting: Not yet known

Economic Significance

At €951,014,187.82, this framework agreement represents a significant investment in medical consumables for the Centre Hospitalier Universitaire de Clermont-Ferrand and the PHARMAUVERGNE group of purchasers. The contract will:

• Support Hospital Operations: Supply medical consumables across multiple clinical specialities
• Support Large Enterprises: Numerous large medical device suppliers
• Provide Medium-Term Delivery: Maximum 48 months
• Ensure Medical Capability: Improve the supply of medical consumables for hospital operations
• Enable Operational Efficiency: Comprehensive supply of medical consumables across nine lots
• Support Regional Development: Contribute to the healthcare market in the Clermont-Ferrand region

Future Procurement Opportunities

With these framework agreements now in place, future opportunities include:

• Re-tender: Expected after the completion of the framework agreements
• Related Works: Additional medical consumables procurements
• Subcontracting: Potential opportunities with the winning suppliers
• Other Hospital Projects: Similar medical consumables procurement opportunities
• Other Public Sector Health Procurements: Similar medical consumables opportunities

Opportunities for Suppliers

While these contracts are awarded, opportunities remain for medical consumables suppliers:

• Re-tender: Prepare for future procurement cycles
• Subcontracting: Potential opportunities with the winning suppliers
• Related Works: Other medical consumables procurements
• Other French Public Sector Health Authorities: Similar medical consumables procurements
• Other Hospital Groups: Monitor further medical consumables opportunities

What Businesses Should Watch

• Centre Hospitalier Universitaire de Clermont-Ferrand's future procurement notices
• Other French public sector health tenders
• Medical consumables market trends
• Changes to French procurement regulations
• Medical device and consumable developments
• Further medical consumables procurement opportunities in the healthcare sector

FranceTenders.com Procurement Intelligence

This medical consumables framework agreement procurement is a notable example of French public sector health procurement. Several features stand out:

• Scale: €951,014,187.82 maximum framework value
• Price-based evaluation: 100% price
• Large winners: Numerous large medical device suppliers
• Nine lots: Covering multiple clinical specialities
• Competition: 195 tenders received electronically
• Medium-term project: Maximum 48 months
• Comprehensive scope: Medical consumables across urology, nephrology, urodynamic exploration, dressings, gynaecology, pulmonary, anaesthesia, cardiology, biopsy and drainage, and nervous system exploration
• Specialised supplies: Consumable medical devices for multiple clinical specialities

For suppliers, this procurement highlights the importance of:

• Competitive pricing: 100% price-based evaluation
• Medical consumables expertise: Ability to deliver medical consumables across clinical specialities
• Product range capability: Ability to supply a broad range of medical devices
• Public sector experience: Understanding of French hospital requirements

Supplier Takeaways

• Offer competitive pricing – 100% of evaluation is price-based
• Showcase medical consumables expertise
• Demonstrate product range capability across clinical specialities
• Develop public sector experience with French hospital authorities
• Monitor Centre Hospitalier Universitaire de Clermont-Ferrand and French public sector health procurement opportunities
• Prepare for subcontracting and future procurement opportunities

Key Takeaways

• Centre Hospitalier Universitaire de Clermont-Ferrand awarded framework agreements worth €951,014,187.82 for medical consumables to numerous suppliers across nine lots
• Nine lots: urology/nephrology, urodynamic exploration, dressings/wound treatment, gynaecology, pulmonary approach, anaesthesia/intensive care, cardiology, biopsy/drainage, and nervous system exploration
• Maximum duration: 48 months (initial 12 months plus 3 renewals of 12 months)
• Evaluation: Price (100%)
• 195 tenders received electronically
• Winners are large enterprises
• Subcontracting not yet known
• No EU funding
• Covered by GPA: Yes
• Framework agreement, without reopening of competition
• Strategic procurement: Approach to reducing environmental impacts – Other
• Contracts concluded on 01/03/2026

Conclusion

These medical consumables framework agreements ensure the supply of medical consumables for the Centre Hospitalier Universitaire de Clermont-Ferrand and the PHARMAUVERGNE group of purchasers, supporting hospital medical operations across multiple clinical specialities. By awarding the contracts to numerous large enterprise suppliers, the Centre Hospitalier Universitaire de Clermont-Ferrand secures reliable suppliers with the capability to deliver comprehensive medical consumables.

The 100% price evaluation reflects the price-focused nature of this medical consumables procurement. The maximum 48-month duration, the comprehensive scope and the specialised supplies reflect the specific operational and strategic context of the medical consumables procurement.

For suppliers, this procurement highlights the importance of competitive pricing, medical consumables expertise, product range capability, and public sector experience in winning French public sector health contracts.

Frequently Asked Questions

Q: Who is the contracting authority?

Ans: Centre Hospitalier Universitaire de Clermont-Ferrand, a body governed by public law operating in health in France, on behalf of a group of purchasers (PHARMAUVERGNE).

Q: What is the value of the contract?

Ans: Maximum framework value €951,014,187.82.

Q: Who are the winners?

Ans: Numerous suppliers across nine lots, including AMBU SARL, ASEPT INMED, BOSTON SCIENTIFIC, BBRAUN, VYGON, MEDTRONIC FRANCE SAS, LABORATOIRES PAUL HARTMANN, TELEFLEX MEDICAL SAS, ABBOTT MEDICAL France, BIOTRONIK FRANCE, EDWARDS LIFESCIENCES SAS, MICROPORT (LIVANOVA), STRYKER FRANCE, MICROVENTION® EUROPE, BALT EXTRUSION, and PENUMBRA FRANCE SAS.

Q: What supplies are covered?

Ans: Medical consumables across nine lots: urology/nephrology, urodynamic exploration, dressings/wound treatment, gynaecology, pulmonary approach, anaesthesia/intensive care, cardiology, biopsy/drainage, and nervous system exploration.

Q: What were the evaluation criteria?

Ans: Price (100%) – price is the only award criterion.

Q: How long is the contract?

Ans: Maximum 48 months (initial 12 months from 01/03/2026 to 28/02/2027, plus 3 renewals of 12 months; expected completion 28/02/2030).

Q: How many tenders were received?

Ans: 195 tenders received electronically.

Q: Is this contract funded by the EU?

Ans: No, the procurement is not financed with EU funds.

Q: What is the review body?

Ans: Tribunal administratif de Clermont-Ferrand.

Q: What is the lot structure?

Ans: Nine lots – LOT-0001 to LOT-0009.

Q: Is subcontracting allowed?

Ans: Subcontracting is not yet known.

Q: What is the main CPV classification?

Ans: 33140000 Medical consumables.

Source: EU Official Journal, Contract Award Notice 686454-2026, OJ S 193/2026, published 06 October 2026.

```